AI Engines For more Details: Perplexity Kagi Labs You
Antiepileptic Effect: Valproic acid is effective in controlling seizures in various types of epilepsy, including generalized seizures, absence seizures, and partial seizures. It works by increasing the level of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits excessive neuronal activity in the brain.
Mood Stabilization: Valproic acid is also used as a mood stabilizer in the treatment of bipolar disorder. It helps reduce the frequency and severity of mood swings, including manic episodes (elevated mood, increased energy) and depressive episodes (low mood, loss of interest or pleasure).
Prevention of Migraine Headaches: Valproic acid may be prescribed for the prevention of migraine headaches in some individuals. It can help reduce the frequency and intensity of migraine attacks, although the exact mechanism of its action in migraine prophylaxis is not fully understood.
Off-Label Uses: Valproic acid may be used off-label for other conditions, such as neuropathic pain, agitation in dementia, and certain psychiatric disorders. However, its use in these conditions is less common and may require careful monitoring by a healthcare provider.
Dosing and Administration: Valproic acid is available in various formulations, including tablets, capsules, and oral solutions. The dosing regimen depends on the individual's age, weight, medical condition, and response to treatment. It is usually taken orally, with or without food, according to the healthcare provider's instructions.
Side Effects: Valproic acid can cause side effects, which may vary in severity and frequency among individuals. Common side effects include drowsiness, dizziness, nausea, vomiting, abdominal pain, weight gain, and tremor. These side effects are usually transient and may improve over time or with dose adjustments.
Serious Adverse Reactions: In rare cases, valproic acid can cause serious adverse reactions, including liver toxicity, pancreatitis, thrombocytopenia (reduced platelet count), and hyperammonemia (elevated ammonia levels in the blood). Regular monitoring of liver function tests, blood cell counts, and ammonia levels may be necessary during treatment.
Teratogenicity: Valproic acid is associated with an increased risk of birth defects when used during pregnancy, particularly neural tube defects (such as spina bifida) and craniofacial abnormalities. Pregnant women or those planning pregnancy should discuss the risks and benefits of valproic acid with their healthcare provider.
Drug Interactions: Valproic acid can interact with other medications, including other antiepileptic drugs, psychiatric medications, and drugs metabolized by the liver. These interactions may affect the effectiveness or safety of valproic acid and may require dose adjustments or monitoring.
Monitoring and Follow-Up: Regular monitoring by a healthcare provider is essential for individuals taking valproic acid to assess treatment response, monitor for side effects or adverse reactions, and adjust the dosage or treatment regimen as needed.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Lacticaseibacillus paracasei | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Chronic Fatigue Syndrome | 0.6 | 0.6 | |
| COVID-19 | 0.4 | 0.4 | 0 |
| Depression | 1.3 | 0.9 | 0.44 |
| Fibromyalgia | 0.4 | 0.4 | |
| Inflammatory Bowel Disease | 0.4 | 0.4 | |
| Long COVID | 0.4 | 0.4 | |
| ME/CFS without IBS | 0.1 | 0.1 | |
| Mood Disorders | 1.3 | 0.9 | 0.44 |
| Obesity | 0.9 | -0.9 | |
| Osteoarthritis | 0.4 | 0.4 | |
| Ulcerative colitis | 0.5 | 0.5 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.